Measurement of Infliximab and Anti-Infliximab Antibody Levels Can Help Distinguish Maintenance Versus Loss of Response
[摘要]
[发布日期] [发布机构]
[效力级别] [学科分类] 解剖和生理学
[关键词] Hypertension;epidemiology;cardiovascular;renal;economic burden;biomarker;risk assessment [时效性]
